| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,868.0 | 1,795.0 |
| Profit before tax | 279.0 | 91.0 |
| Net income | 123.0 | -123.0 |
| EPS (diluted, $ a share) | $0.91 | $-0.88 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +4.1% |
|---|
10-Q filed with the SEC, NYSE: DD. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
DuPont de Nemours, Inc.: key numbers
- Share price
- $150.14Close, Nov 17
- Market cap
- $19.9B
- Shares outstanding
- 132.53MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Plastic Materials, Synth Resins & Nonvulcan ElastomersSIC 2821
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from DuPont de Nemours, Inc.
All →DuPont de Nemours SVP & General Counsel Erik T. Hoover Sells $634K of Stock
Erik T. Hoover, SVP & General Counsel, sold 4,203 shares of DuPont de Nemours, Inc. at $150.82 a share, worth $634K in total on Nov 9, 2026. Shares held after the trade: 38,798 (-9.8%).
- Value
- $634K
- Shares
- 4,203
- Price
- $150.82
- Role
- SVP & General Counsel
- Holding change
- -9.8%
- Trade date
- Nov 9, 2026
DuPont de Nemours CEO Lori Koch Sells $349K of Stock
Lori Koch, CEO, sold 2,311 shares of DuPont de Nemours, Inc. at $151.15 a share, worth $349K in total on Nov 9, 2026. Shares held after the trade: 115,715 (-2.0%).
- Value
- $349K
- Shares
- 2,311
- Price
- $151.15
- Role
- CEO
- Holding change
- -2.0%
- Trade date
- Nov 9, 2026
DuPont de Nemours Insider Edward D. Breen Sells $13.2M of Stock
Edward D. Breen sold 89,845 shares of DuPont de Nemours, Inc. at $146.41 a share, worth $13.2M in total on Nov 5, 2026. Shares held after the trade: 127,276 (-41.4%).
- Value
- $13.2M
- Shares
- 89,845
- Price
- $146.41
- Holding change
- -41.4%
- Trade date
- Nov 5, 2026
DuPont de Nemours Earnings Call: Key Takeaways
DuPont delivered a strong Q3 2026 beat-and-raise, driven by 5% organic growth, productivity gains, and robust aerospace/healthcare demand, despite ongoing geopolitical headwinds in the Middle East water business.
- Call
- Nov 3, 2026, 8:00 AM ET
DuPont de Nemours Financial Results
DuPont reported third quarter 2026 results with net sales of $1.9 billion, up 4% year-over-year, and organic sales growth of 5%. The company exceeded its quarterly guidance and raised its full-year 2026 outlook, driven by strong performance in Healthcare & Water Technologies and Diversified Industrials.
- Term
- Q3 2026
“We delivered another quarter of consistent, high-quality performance, once again exceeding our financial guidance. Mid-single-digit organic growth, strong operating leverage and disciplined capital allocation drove significant adjusted EPS growth. Additionally, we delivered strong free cash flow performance, with 121% conversion, underscoring the quality of our earnings and effective execution.”
Lori Koch, DuPont Chief Executive Officer
“We are executing from a position of strength and remain focused on unlocking the full potential of our portfolio to deliver sustained long-term value creation.”
Lori Koch, DuPont Chief Executive Officer